Cargando…

Crossing enhanced and high fidelity SpCas9 nucleases to optimize specificity and cleavage

BACKGROUND: The propensity for off-target activity of Streptococcus pyogenes Cas9 (SpCas9) has been considerably decreased by rationally engineered variants with increased fidelity (eSpCas9; SpCas9-HF1). However, a subset of targets still generate considerable off-target effects. To deal specificall...

Descripción completa

Detalles Bibliográficos
Autores principales: Kulcsár, Péter István, Tálas, András, Huszár, Krisztina, Ligeti, Zoltán, Tóth, Eszter, Weinhardt, Nóra, Fodor, Elfrieda, Welker, Ervin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6389135/
https://www.ncbi.nlm.nih.gov/pubmed/28985763
http://dx.doi.org/10.1186/s13059-017-1318-8
_version_ 1783397894731071488
author Kulcsár, Péter István
Tálas, András
Huszár, Krisztina
Ligeti, Zoltán
Tóth, Eszter
Weinhardt, Nóra
Fodor, Elfrieda
Welker, Ervin
author_facet Kulcsár, Péter István
Tálas, András
Huszár, Krisztina
Ligeti, Zoltán
Tóth, Eszter
Weinhardt, Nóra
Fodor, Elfrieda
Welker, Ervin
author_sort Kulcsár, Péter István
collection PubMed
description BACKGROUND: The propensity for off-target activity of Streptococcus pyogenes Cas9 (SpCas9) has been considerably decreased by rationally engineered variants with increased fidelity (eSpCas9; SpCas9-HF1). However, a subset of targets still generate considerable off-target effects. To deal specifically with these targets, we generated new “Highly enhanced Fidelity” nuclease variants (HeFSpCas9s) containing mutations from both eSpCas9 and SpCas9-HF1 and examined these improved nuclease variants side by side to decipher the factors that affect their specificities and to determine the optimal nuclease for applications sensitive to off-target effects. RESULTS: These three increased-fidelity nucleases can routinely be used only with perfectly matching 20-nucleotide-long spacers, a matching 5′ G extension being more detrimental to their activities than a mismatching one. HeFSpCas9 exhibit substantially improved specificity for those targets for which eSpCas9 and SpCas9-HF1 have higher off-target propensity. The targets can also be ranked by their cleavability and off-target effects manifested by the increased fidelity nucleases. Furthermore, we show that the mutations in these variants may diminish the cleavage, but not the DNA-binding, of SpCas9s. CONCLUSIONS: No single nuclease variant shows generally superior fidelity; instead, for highest specificity cleavage, each target needs to be matched with an appropriate high-fidelity nuclease. We provide here a framework for generating new nuclease variants for targets that currently have no matching optimal nuclease, and offer a simple means for identifying the optimal nuclease for targets in the absence of accurate target-ranking prediction tools. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13059-017-1318-8) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6389135
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-63891352019-03-19 Crossing enhanced and high fidelity SpCas9 nucleases to optimize specificity and cleavage Kulcsár, Péter István Tálas, András Huszár, Krisztina Ligeti, Zoltán Tóth, Eszter Weinhardt, Nóra Fodor, Elfrieda Welker, Ervin Genome Biol Research BACKGROUND: The propensity for off-target activity of Streptococcus pyogenes Cas9 (SpCas9) has been considerably decreased by rationally engineered variants with increased fidelity (eSpCas9; SpCas9-HF1). However, a subset of targets still generate considerable off-target effects. To deal specifically with these targets, we generated new “Highly enhanced Fidelity” nuclease variants (HeFSpCas9s) containing mutations from both eSpCas9 and SpCas9-HF1 and examined these improved nuclease variants side by side to decipher the factors that affect their specificities and to determine the optimal nuclease for applications sensitive to off-target effects. RESULTS: These three increased-fidelity nucleases can routinely be used only with perfectly matching 20-nucleotide-long spacers, a matching 5′ G extension being more detrimental to their activities than a mismatching one. HeFSpCas9 exhibit substantially improved specificity for those targets for which eSpCas9 and SpCas9-HF1 have higher off-target propensity. The targets can also be ranked by their cleavability and off-target effects manifested by the increased fidelity nucleases. Furthermore, we show that the mutations in these variants may diminish the cleavage, but not the DNA-binding, of SpCas9s. CONCLUSIONS: No single nuclease variant shows generally superior fidelity; instead, for highest specificity cleavage, each target needs to be matched with an appropriate high-fidelity nuclease. We provide here a framework for generating new nuclease variants for targets that currently have no matching optimal nuclease, and offer a simple means for identifying the optimal nuclease for targets in the absence of accurate target-ranking prediction tools. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13059-017-1318-8) contains supplementary material, which is available to authorized users. BioMed Central 2017-10-06 /pmc/articles/PMC6389135/ /pubmed/28985763 http://dx.doi.org/10.1186/s13059-017-1318-8 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Kulcsár, Péter István
Tálas, András
Huszár, Krisztina
Ligeti, Zoltán
Tóth, Eszter
Weinhardt, Nóra
Fodor, Elfrieda
Welker, Ervin
Crossing enhanced and high fidelity SpCas9 nucleases to optimize specificity and cleavage
title Crossing enhanced and high fidelity SpCas9 nucleases to optimize specificity and cleavage
title_full Crossing enhanced and high fidelity SpCas9 nucleases to optimize specificity and cleavage
title_fullStr Crossing enhanced and high fidelity SpCas9 nucleases to optimize specificity and cleavage
title_full_unstemmed Crossing enhanced and high fidelity SpCas9 nucleases to optimize specificity and cleavage
title_short Crossing enhanced and high fidelity SpCas9 nucleases to optimize specificity and cleavage
title_sort crossing enhanced and high fidelity spcas9 nucleases to optimize specificity and cleavage
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6389135/
https://www.ncbi.nlm.nih.gov/pubmed/28985763
http://dx.doi.org/10.1186/s13059-017-1318-8
work_keys_str_mv AT kulcsarpeteristvan crossingenhancedandhighfidelityspcas9nucleasestooptimizespecificityandcleavage
AT talasandras crossingenhancedandhighfidelityspcas9nucleasestooptimizespecificityandcleavage
AT huszarkrisztina crossingenhancedandhighfidelityspcas9nucleasestooptimizespecificityandcleavage
AT ligetizoltan crossingenhancedandhighfidelityspcas9nucleasestooptimizespecificityandcleavage
AT totheszter crossingenhancedandhighfidelityspcas9nucleasestooptimizespecificityandcleavage
AT weinhardtnora crossingenhancedandhighfidelityspcas9nucleasestooptimizespecificityandcleavage
AT fodorelfrieda crossingenhancedandhighfidelityspcas9nucleasestooptimizespecificityandcleavage
AT welkerervin crossingenhancedandhighfidelityspcas9nucleasestooptimizespecificityandcleavage